Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 489 | 554 | 461 | 402 | 492 |
| Gross Profit | 489 | 554 | 461 | 402 | 492 |
| Operating Expenses | 3,198 | 4,004 | 2,422 | 48,327 | 2,300 |
| Operating Income | -2,709 | -3,450 | -1,961 | -47,925 | -1,808 |
| Interest Expense | 2 | 2 | 2 | 3 | 5 |
| Other Income | 41 | -43 | -27 | 83 | 33 |
| Pre-tax Income | -2,670 | -3,495 | -1,990 | -47,845 | -1,780 |
| Net Income Continuous | -2,670 | -3,495 | -1,990 | -47,845 | -1,780 |
| Net Income | $-2,670 | $-3,495 | $-1,990 | $-47,845 | $-1,780 |
| EPS Basic Total Ops | -0.60 | -0.84 | -0.60 | -18.01 | -0.72 |
| EPS Basic Continuous Ops | -0.56 | -0.80 | -0.57 | -18.08 | -0.68 |
| EPS Diluted Total Ops | -0.60 | -0.84 | -0.60 | -18.01 | -0.72 |
| EPS Diluted Continuous Ops | -0.56 | -0.80 | -0.57 | -18.07 | -0.68 |
| EBITDA(a) | $-2,620 | $-3,368 | $-1,887 | $-1,751 | $-1,670 |